Article Figures & Data
Tables
- Table 1
Patient characteristics
Patient characteristics Study group (n=65) Control group (n=65) χ2/t P value Age at treatment (years) 48.93±8.91 48.89±8.45 0.038 0.846 Female sex, n (%) 46 (71) 46 (72) 0.026 0.979 Left side, n (%) 33 (51) 34 (52) 0.031 0.861 Smoking history, n (%) 21 (32) 18 (28) 0.330 0.566 History of arterial hypertension, n (%) 48 (74) 51 (78) 0.381 0.537 Mean GCS score 14.01±1.23 14.92±1.19 −1.460 0.147 Hunt and Hess Scale, n (%) 0.135 0.713 Grade 0 43 (66) 41 (63) Grade 1 22 (34) 24 (37) Modified Fisher classification, n (%) Grade 0 21 (32) 17 (26) 2.757 0.599 Grade 1 9 (14) 6 (9) Grade 2 13 (20) 11 (17) Grade 3 15 (23) 13 (20) Grade 4 7 (11) 8 (12) Site of aneurysm, n (%) Posterior communicating artery 30 (46) 32 (49) 1.025 0.599 Middle cerebral artery 9 (14) 12 (18) Anterior communicating artery 26 (40) 21 (32) Shape of aneurysm, n (%) Cystic 41 (63) 43 (66) 0.836 0.841 Spindle 11 (17) 14 (21) Lobulated 12 (18) 9 (14) Multiple forms 21 (32) 23 (35) Diameter of aneurysm, n (%) <5 mm 41 (63) 40 (62) 0.537 0.764 5–15 mm 21 (32) 20 (31) GCS, Glasgow Coma Scale.
- Table 2
Comparison of GOS grading
GOS grade Study (n=65)
n (%)Control (n=65)
n (%)χ2 P value Grade 1 53 (82) 23 (35) 28.509 <0.001* Grade 2 10 (15) 21 (32) 5.125 0.024 Grade 3 2 (3) 15 (23) 11.437 0.001* Grade 4 0 (0) 6 (9) 6.290 0.012* Grade 5 0 0 *Difference is statistically significant at p<0.05.
GOS, Glasgow Outcome Scale.
- Table 3
Comparison of activity ability and indicators of brain injury
Study group (n=65) Control group (n=65) t P value Mean activity score Before treatment 43.59±4.29 44.83±4.02 −1.7 0.092 After treatment 73.29±6.39 66.94±5.98 5.85 <0.001* Mean NSE, µg/L Before treatment 41.98±6.93 42.12±7.01 −0.115 0.909 After treatment 11.02±4.08 19.38±3.87 −11.986 <0.001* Mean S100β, µg/L Before treatment 18.98±2.39 19.08±2.41 −0.238 0.812 After treatment 4.03±0.38 8.38±0.42 −61.92 <0.001* *Difference is statistically significant at p<0.05.
NSE, neuron-specific enolase; S100β, astrocyte-derived protein.
- Table 4
Comparison of results of follow-up
Study group
(n=65)Control group
(n=65)χ2/t P value Postoperative hospital stay (days) 17.65 (1.29) 23.0 (1.32) −23.501 <0.001* Pulmonary infection, n (%) 12 (18) 28 (43) 9.244 0.002* Intracranial infection, n (%) 2 (3) 42 (64) 54.968 <0.001* Brain herniation, n (%) 4 (6) 5 (8) 0.119 0.730 *Difference is statistically significant at p<0.05.
Vol 70 Issue 5
Table of Contents
